E
ERAS
Erasca, Inc.
16.03
+0.57+3.69%After Hours: 15.55 -0.48 -2.99%19:30 10/09 EDT
OPEN/PREV CLOSE15.42/15.46
TODAY RANGE15.22-16.20
VOL7.77M
MARKET CAP5.61B
52 WEEK RANGE2.105-24.28
AVG VOL (3M)4.44M
% TURNOVER1.97%
TURNOVER--
P/E (TTM)-16.7889
% RANGE6.37%
EPS(TTM)-0.9548
P/E(FORWARD)-16.1929
P/B13.85
BVPS1.158
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.86B
SHARES OUTSTANDING349.76M
NEXT EARNINGS11/10-11/16
FREE FLOAT303.45M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·5d ago
Verastem: A Two-For-One Clinical Readout In October And A Commercial Launch
TipRanks·5d ago
Erasca participates in a conference call with JPMorgan
Seeking Alpha·5d ago
Erasca: Revolution's Approval Just Took Risk Out Of The Fast Follower
Seeking Alpha·10/01 11:44
These ten healthcare stocks posted the biggest one-month losses
NASDAQ·09/25 19:20
Notable Friday Option Activity: APP, ERAS, CRDO
Simply Wall St·09/23 12:35
Did Fiduciary Duty Probes Just Shift Erasca Stock's Investment Narrative?
Seeking Alpha·09/17 14:10
10 mid-cap healthcare stocks with the strongest momentum grades
Seeking Alpha·09/17 13:45
These mid-cap stocks have A+ momentum grades and over 100% YTD growth
Dow Jones·09/17 11:30
S&P 500 Futures Climb In Premarket Trading; Generac Holdings, UDR Lead
Simply Wall St·09/16 22:21
Erasca (ERAS) Dropped, So What Is Driving Attention Now?
Simply Wall St·09/11 03:30
What Erasca Stock's Pipeline Data Update Means For Shareholders
TipRanks·09/02 12:18
J.P. Morgan Keeps Their Buy Rating on Erasca (ERAS)
TipRanks·08/27 13:10
Erasca price target raised to $33 from $25 at JPMorgan
Simply Wall St·08/26 17:19
Should FDA Fast Track for ERAS-0015’s Pan-RAS Glue Require Action From Erasca (ERAS) Investors?